Mansoor Ali* and Zaheed Ahmed
Male kidney transplant recipients and matched control men without kidney transplants showed similar rates of prostate cancer diagnosis, clinical prostate cancer features, and prostate cancer-specific death. In comparison to control males, the likelihood of developing an advanced or poorly differentiated prostate cancer did not rise with time in transplant recipients. More than half of transplant recipients had been on immunosuppression for more than 9 years, and almost half had received their transplants before PSA testing was a standard part of the pre-transplantation examination. Thus, it is unlikely that immunosuppression following kidney transplantation will have a negative impact on the beginning or advancement of prostate cancer.
इस लेख का हिस्सा
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Telugu 